UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000002879
Receipt No. R000003455
Scientific Title Phase I study of pegylated liposomal doxorubicin (PLD) in combination with docetaxel (TXT) in recurrent or refractory ovarian cancer (epithelial ovarian carcinoma, fallopian tube carcinoma, or primary peritoneal carcinoma)
Date of disclosure of the study information 2009/12/12
Last modified on 2019/05/10 11:45:35

No. Disposal Last modified on Item of update
1 Insert 2009/12/11 15:32:05
2 Update 2010/01/05 17:09:11 Condition
Narrative objectives1
Primary outcomes
Key secondary outcomes
3 Update 2010/01/05 17:12:49 Public title
4 Update 2010/01/06 14:20:38 Key inclusion criteria
Key exclusion criteria
5 Update 2010/01/06 14:23:50 Gender
6 Update 2011/06/24 14:25:20 Name of person sending information
Organization
Division name
Address
Post marketing survey by drug manufacture etc., specified by Japanese law.
7 Update 2011/06/24 14:27:02 Recruitment status
8 Update 2015/04/14 17:53:40 TEL
Email
TEL
Email
Email1
9 Update 2015/12/11 14:01:17 Publication of results
Results
10 Update 2016/04/14 14:10:57 Name of primary sponsor
Organization
Co-sponsor
Co-sponsor
Name of secondary funder(s)
Name of secondary funder(s)
Institutions
11 Update 2017/09/04 07:26:52 Recruitment status
12 Update 2019/05/10 11:45:35 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email


Contact us.